Merck Reports To Federal Court To Oversee $4.85 Billion Vioxx Settlement
July 17, 2008
On July 17, 2008, Merck & Co., Inc. reported to the federal court charged with overseeing the $4.85 billion Vioxx settlement that more than 97 percent of eligible claimants have enrolled in the program and that qualified claimants will begin to receive interim settlement payments in August 2008. The settlement is expected to resolve nearly 50,000 lawsuits filed by thousands of plaintiffs who suffered heart attacks and strokes while taking Vioxx. Partner Chris Seeger, one of the lead negotiators of the settlement for plaintiffs, noted: "This is a great day for the plaintiffs injured by Vioxx who will within weeks begin to receive compensation for their injuries. On a personal and professional level, I couldn't be happier for my clients."Our Practices
- Asbestos
- Class Actions
- Commercial Litigation
- Defective Products
- Drug Injury
- Personal Injury
- Securities Fraud
- Toxic Exposure
- Whistleblower Claims
Current Investigations
General
Drug Injury
- Actos
- Accutane
- Fosamax
- GranuFlo/NaturaLyte
- Gadolinium
- Ocella, Yasmin, Yaz
- Pradaxa
- Sleeping Pills
- SSRIs
- Topamax
- Tylenol
- Zithromax/Z-pack
- Zocor/Simvastatin
Medical Devices
- Da Vinci Robot
- DePuy Hip Recall
- Mirena Lawsuit
- Stryker Recall
- Stryker Lawsuit
- Transvaginal Mesh
- Zimmer Hip Implant
Product Liability
- Aveeno Lawsuit
- Atlas Roofing Lawsuit
- Avon/Clarins Products
- AZEK Decking
- Chinese Drywall
- Chrysler Lock-Ups
- Demilec Insulation
- Electrolux Lawsuit
- Energy Drink Lawsuit
- Flushmate Systems
- Ford 5.4L Engine
- Ford & Mercury Transmissions
- Ford Mileage Claims
- GAF Decking
- Jeld-Wen Low E
- LP/ABTCO TrimBoard
- Norcold Lawsuit
- Pozzi and Jeld-Wen
- Remington Lawsuit
- TimberTech Decking
- Toyota Power Windows
- Trex Decking Lawsuit
Food
Pending Settlements
Newsletter Signup










